Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

37 results about "Hemagglutination Inhibition Tests" patented technology

Serologic tests in which a known quantity of antigen is added to the serum prior to the addition of a red cell suspension. Reaction result is expressed as the smallest amount of antigen which causes complete inhibition of hemagglutination.

GeXP rapid detection kit for identifying eight types of porcine viral diseases and primer group thereof

The invention discloses a GeXP rapid detection kit for identifying eight types of porcine viral diseases and a primer group thereof. Nine pairs of specific primers and a pair of universal primers are designed by the inventor based on research of a GeXP system, accordingly, a GeXP rapid detection method for identifying the eight types of porcine viral diseases is established, and the corresponding detection kit is prepared. The GeXP rapid detection method and the detection kit have the advantages of good specificity, high sensitivity, convenience, high efficiency and the like and can be used for simultaneously detecting and identifying eight types of pathogens. Compared with identification results of conventional experiment methods such as virus isolation and hemagglutination inhibition test, the coincidence rate of the GeXP rapid detection method reaches 100%. The GeXP rapid detection method and the detection kit can be used for effectively solving amplification preference in a multiplex-PCR (polymerase chain reaction) process, provide simple, convenient and high-throughput detection means for detection of main porcine common infectious diseases and pathogens thereof, meet practical requirements and have a broad application prospect.
Owner:GUANGXI VETERINARY RES INST

Primer pair for identifying newcastle disease virus and multi-subtype avian influenza virus and application thereof

The invention discloses a primer pair for identifying newcastle disease virus and multi-subtype avian influenza virus and an application thereof. The PCR primer pair composition provided by the invention comprises primer pair NDV, primer pair H3V, primer pair H5V, and primer pair H9V; the PCR primer pair composition is applicable to the preparation of reagents for the diagnosis or auxiliary diagnosis of newcastle disease and avian influenza, or to the preparation of reagents for the identification or auxiliary identification of newcastle disease virus and multi-subtype avian influenza virus. When the PCR primer pair composition provided by the invention is used to simultaneously detect newcastle disease virus, H3, H5 and H9-subtype avian influenza virus, the specificity is strong; the sensitivity is 1EID50 / 100 microliters, 1EID50 / 100 microliters, 1*10-2EID50 / 100 microliters, and 1EID50 / 100 microliters respectively; compared with identification results of routine test methods such as virus isolation and hemagglutination inhibition tests, the results obtained by using the PCR primer pair composition of the invention has a coincidence rate of up to 100%; the PCR primer pair composition provided by the invention is applicable to the development of corresponding multiplex RT-PCR kits for the clinical diagnosis and epidemiological control of newcastle disease and avian influenza.
Owner:CHINA AGRI UNIV

A rapid antigen detection method for inactivated oil emulsion vaccine against avian influenza finish products

ActiveCN103235139ADoes not destroy hemagglutination titerDoes not destroy antigenicityBiological testingOil emulsionHaemagglutination inhibition
The present invention discloses a rapid antigen detection method for inactivated oil emulsion vaccine against avian influenza finish products, and the method comprises the following steps of: 1) mixing uniformly isopropyl myristate and the inactivated oil emulsion vaccine against avian influenza by thoroughly shaking, centrifuging, and separating a water phase layer; 2) performing HA titer detection to the water phase of the vaccine obtained in the step 1); 3) according to the detection result of the HA titer detection of the water phase of the vaccine in step 2), taking the water phase of the inactivated oil emulsion vaccine against avian influenza of step 1) to prepare a 4HAU vaccine antigen diluent; and 4) performing hemagglutination inhibition tests by using the 4HAU vaccine antigen diluent prepared in step 3), wherein a HI titer is expressed as the highest dilution serum that completely inhibits the 4HAU antigen. The method of the invention does not destroy the hemagglutination titer and antigenicity of vaccine antigens, can quickly and accurately determine the HI titer of the water phase of the inactivated oil emulsion vaccine against avian influenza finish products and analyze differences in antigenicity, and reagents in use are safety and non-toxic for human and environment, and are cheap and readily available.
Owner:ZHAOQING DAHUANONG BIOLOGIC PHARMA +2

Blight hemagglutinin detecting analysis system

The invention discloses an analysis system for blood clotting in plague used for carrying out tests on immunological blood clotting or blood clotting inhibition to such plagues as bird flu, swine fever and foot and mouth disease. The invention comprises hardware and test program software, wherein the hardware comprises a blood clotting image acquisition instrument and a computer, and the software comprises a database module, an image comparison module and a master control module. The image comparison module compares an original image of a tested sample in the blood clotting test acquired by the blood clotting image acquisition instrument with a standard blood clotting image model in the database module; if the tested sample image acquired has the same characteristics in blood clotting with a certain standard blood clotting image, then the judgment result information corresponding to the standard blood clotting image is taken as the test result of the tested sample; and the test program software tests and analyzes the tested sample image and manages the test results data, thereby simplifying and facilitating the operation, raising standardization degree of the test, test precision and testing efficiency and being convenient for searching, filing, statistics and plague tracing.
Owner:杨傲冰

Polymerase chain reaction (PCR) primer pair for identifying H9 subtype avian influenza virus and application thereof

The invention discloses a polymerase chain reaction (PCR) primer pair for identifying an H9 subtype avian influenza virus (AIV) and application thereof. The PCR primer pair disclosed by the invention is composed of two single chain deoxyribonucleic acids (DNAs), wherein the two single chain DNAs are single chain DNAs shown in SEQ ID NO:1 and SEQ ID NO:2 in a sequence table. The HA gene of the H9 subtype AIV in a sample can be subjected to specific amplification, and the length of a target segment is 425bp. The method is free of cross reaction on H3, H4, H5 and other subtype AIVs, and a newcastle disease virus, avian infectious bronchitis, an infectious bursal disease virus, an infectious laryngotracheitis virus and the like; the minimum detectable quantity of virus allantoic fluid is 1*10<4.25>EID50/100mu L. Compared with the conventional methods such as a hemagglutination inhibition test of the virus and the like, the accordance rate of the identification result is 100%. A rapid, specific and sensitive detection means is provided for identification of the H9 subtype AIV. The PCR primer pair can be applied to rapid diagnosis of a disease caused by the H9 subtype AIV, and has a good application prospect in the aspects of clinical diagnosis and epidemiological investigation.
Owner:LIAOCHENG UNIV

QX-type infectious bronchitis virus (IBV) hemagglutination inhibition test antigens, preparation method thereof and application

The invention relates to QX-type infectious bronchitis virus (IBV) hemagglutination inhibition test antigens, a preparation method thereof and application. A preparation method for an HI antigen comprises the following steps of inoculating 10<4>-10<7> EID<50> of QX-type IBV strains to chicken embryos, carrying out incubation for virus multiplication at a temperature of 37 degrees centigrade, after36-48h, taking out the chicken embryos, carrying out cooling for 6-16h at the temperature of 2-8 degrees centigrade, collecting chicken embryo allantoic liquid, uniformly mixing concentrated chickenembryo allantoic liquid with I-type phosphatase C, carrying out shaker action for 2-2.5h at the temperature of 37 degrees centigrade, and then carrying out placement for 21-35d at the temperature of 2-8 degrees centigrade to obtain antigens. The HI antigens and the detection method provided by the invention are characterized by high specificity, high stability, high sensitivity and high efficiency. Rapid detection can be carried out on clinical serum samples within 2h. The HI antigens and the detection method can be widely applied to quarantine and diagnosis of IB and detection of immunized antibodies. The HI method for detecting QX-type infectious bronchitis becomes feasible. A practical and scientific method for prevention of the IB is provided. The prevention and control over the disease in poultry production is guided well.
Owner:CHINA AGRI UNIV

Hemagglutination and hemagglutination inhibition test reader

The invention provides an automatic interpretation tool for a hemagglutination and hemagglutination inhibition test result. The tool is a device for automatically generating the result. An interpretation method for the tool comprises the following steps: adjusting a hemagglutination plate support to make erythrocytes form a teardrop shape; carrying out zoning photographing on hemagglutination plate sample holes in a fixed object distance, calculating the teardrop length of the erythrocytes, and finding out a target hole; and processing obtained results, storing original images and interpretation results in a database, carrying out classified statistics according to the test results of a sample and test items, gathering the sample, and outputting the results by clicking a menu. The hemagglutination and hemagglutination inhibition test interpretation device and the statistical method thereof allow 96 samples to be simultaneously interpreted in 4 seconds, so the interpretation speed is much faster than that of manual operation, and the time and the labor are saved. Manual analysis and discrimination are not needed by using the tool, so visual fatigue and misjudgment are avoided, and individual differences are avoided; and the possibility of personnel in contact with pathogens is reduced, and the tool can be connected with a sample information management system to realize automaticmanagement.
Owner:南京市畜牧兽医站 +1

VIb subtype pigeon Newcastle disease positive serum standard substance and preparation method thereof

The invention relates to a preparation method of a VIb subtype pigeon Newcastle disease positive serum standard substance. The HI titer of the positive serum standard substance prepared by the method is not lower than 1:128, the neutralizing titer is not lower than 1:1600, the serum can completely neutralize the VIb subtype pigeon Newcastle disease virus, the positive serum standard substance is used for detecting the specificity of a positive control standard substance and a vaccine seed virus in a hemagglutination inhibition test and an exogenous virus, the accuracy of an antibody detection result can be ensured in the hemagglutination inhibition test, the antibody level of the immunized pigeons is fully reflected, and a guarantee is provided for accurate monitoring of VIb subtype Newcastle disease epidemic strains in pigeons, immunogenicity and specificity detection of pigeon Newcastle disease seed viruses, exogenous virus detection and vaccine immune efficacy evaluation. The invention fills the blank that no standard positive serum exists in the development of VIb subtype pigeon Newcastle disease vaccines and epidemiological investigation. The preparation method of the positive serum comprises the following steps: preparation of a pigeon Newcastle disease LY/2020/Pi strain inactivated vaccine, animal screening, animal immunization, and preparation, purification and inspection of the positive serum.
Owner:ZHONGCHONG XINNUO BIOTECH TAIZHOU CO LTD

Influenza virus antigen dissimilarity calculation method and system

The invention relates to an influenza virus antigen dissimilarity calculation method and system. The method comprises the following steps: acquiring a hemagglutination inhibition titer set obtained by a known hemagglutination inhibition test, wherein the hemagglutination inhibition titer set comprises known hemagglutination inhibition titers; calculating the antigen distance between strains according to the hemagglutination inhibition titer to obtain an antigen distance set; establishing an antigen dissimilar network according to the antigen distance set; mapping nodes in the antigen dissimilar network into low-dimensional dense vectors based on a network embedding technology; and quantitatively calculating the antigen diversity between every two strains according to the low-dimensional dense vector. According to the method and the system, the antigen dissimilarity is modeled based on the network structure, the nonlinear feature learning capability of deep learning on the network structure is exerted, the antigen dissimilarity between every two strains can be quantitatively calculated, the robustness of antigen dissimilarity calculation is improved, and further, antigenicity analysis except for influenza antigen specificity can be supported, and good expandability and practicability are achieved.
Owner:YUNNAN UNIV

Mycoplasma gallisepticum antibody detection reagent, preparation method and application thereof

InactiveCN111707822AIn line with the domestic marketProductiveImmunoassaysMycoplasma antibodyMethyl violet
The invention relates to the technical field of poultry antibody detection reagents, particularly to a mycoplasma gallisepticum antibody detection reagent, a preparation method and application thereof. According to the invention, a mycoplasma gallisepticum culture solution is subjected to a series of treatment on, inactivating is performed, the inactivated antigen bacteria solution and a freeze-drying protective agent are uniformly mixed, and freeze drying is performed to obtain the mycoplasma gallisepticum antibody detection reagent; the reagent can be directly used for a hemagglutination inhibition test; a plate agglutination test can be carried out by adding any one coloring agent of methyl violet, amber red and crystal violet into the reagent containing 4-8HA unit of antigen; the hemagglutination value of the detection reagent reaches 26; and the detection reagent not only improves the hemagglutination titer of the mycoplasma gallisepticum antigen, but also has two purposes, is stable, sensitive, strong in specificity, long in storage life, simple to operate, convenient and fast, does not need special equipment and instruments, and can be used for efficacy test, epidemiologicalinvestigation, clinical sample detection and the like of mycoplasma gallisepticum vaccines.
Owner:兆丰华生物科技(南京)有限公司

Polymerase chain reaction (PCR) primer pair for identifying H9 subtype avian influenza virus and application thereof

The invention discloses a polymerase chain reaction (PCR) primer pair for identifying an H9 subtype avian influenza virus (AIV) and application thereof. The PCR primer pair disclosed by the invention is composed of two single chain deoxyribonucleic acids (DNAs), wherein the two single chain DNAs are single chain DNAs shown in SEQ ID NO:1 and SEQ ID NO:2 in a sequence table. The HA gene of the H9 subtype AIV in a sample can be subjected to specific amplification, and the length of a target segment is 425bp. The method is free of cross reaction on H3, H4, H5 and other subtype AIVs, and a newcastle disease virus, avian infectious bronchitis, an infectious bursal disease virus, an infectious laryngotracheitis virus and the like; the minimum detectable quantity of virus allantoic fluid is 1*10<4.25>EID50 / 100mu L. Compared with the conventional methods such as a hemagglutination inhibition test of the virus and the like, the accordance rate of the identification result is 100%. A rapid, specific and sensitive detection means is provided for identification of the H9 subtype AIV. The PCR primer pair can be applied to rapid diagnosis of a disease caused by the H9 subtype AIV, and has a good application prospect in the aspects of clinical diagnosis and epidemiological investigation.
Owner:LIAOCHENG UNIV

PCR (polymerase chain reaction) primer pair for identifying H3 subtype avian influenza virus and application thereof

The invention discloses a PCR (polymerase chain reaction) primer pair for identifying H3 subtype avian influenza virus and an application thereof. The PCR primer pair provided by the invention comprises two single-stranded DNAs (deoxyribonucleic acids), and the two single-stranded DNAs are the single-stranded DNA as shown in sequence 1 in a sequence table and the single-stranded DNA as shown in sequence 2 in the sequence table. The primer pair provided by the invention has high specificity when used for detecting the H3 subtype avian influenza virus, the sensitivity can reach1EID50 / 100 mu l, and the coincidence rate is 100% in comparison with the identification results obtained by conventional experimental methods, such as virus isolation, hemagglutination inhibition test and the like; and the primer pair can be used for detecting not only buccal swabs and cloacal swabs of sick poultry but also allantoic fluid of the sick poultry, the operation is simple, the popularization is easy, the basic level operation and the application are convenient, and the primer pair can become a useful detection tool for the diagnosis and the epidemiological investigation of the H3 subtype avian influenza virus disease.
Owner:CHINA AGRI UNIV

Full-automatic hemagglutination and hemagglutination inhibition test workstation

PendingCN114675044ARealize multi-position adjustment mobile processingImprove efficiencyMaterial analysisEngineeringStructural engineering
The invention discloses a full-automatic hemagglutination and hemagglutination inhibition test workstation which comprises a storage bottom box, the top of the storage bottom box is fixedly connected with a bottom plate, the top of the storage bottom box is fixedly connected with an upper shell, one side of the upper shell is connected with a door cover through a hinge, one side of the upper shell is provided with a cover opening mechanism, and the cover opening mechanism is connected with the door cover. The hemagglutination inhibition experiment sample detection device has the beneficial effects that the U-shaped fixing plates are additionally arranged, the inner sides of the two U-shaped fixing plates are mounted through different mounting blocks, the bottom plate can accommodate 24 plate positions, the efficiency of detecting a hemagglutination inhibition experiment sample is improved, and the detection accuracy is improved. The time and the cost of manual operation are greatly reduced; by adding the X-axis linear module, the Y-axis linear module and the Z-axis linear module, multi-position adjusting and moving treatment of the fixed box and the pipetting cylinder is realized, and the pipetting efficiency is improved.
Owner:南京应节生物科技有限公司

A rapid antigen detection method for inactivated oil emulsion vaccine against avian influenza finish products

The present invention discloses a rapid antigen detection method for inactivated oil emulsion vaccine against avian influenza finish products, and the method comprises the following steps of: 1) mixing uniformly isopropyl myristate and the inactivated oil emulsion vaccine against avian influenza by thoroughly shaking, centrifuging, and separating a water phase layer; 2) performing HA titer detection to the water phase of the vaccine obtained in the step 1); 3) according to the detection result of the HA titer detection of the water phase of the vaccine in step 2), taking the water phase of the inactivated oil emulsion vaccine against avian influenza of step 1) to prepare a 4HAU vaccine antigen diluent; and 4) performing hemagglutination inhibition tests by using the 4HAU vaccine antigen diluent prepared in step 3), wherein a HI titer is expressed as the highest dilution serum that completely inhibits the 4HAU antigen. The method of the invention does not destroy the hemagglutination titer and antigenicity of vaccine antigens, can quickly and accurately determine the HI titer of the water phase of the inactivated oil emulsion vaccine against avian influenza finish products and analyze differences in antigenicity, and reagents in use are safety and non-toxic for human and environment, and are cheap and readily available.
Owner:ZHAOQING DAHUANONG BIOLOGIC PHARMA +2

Positive serum national standard substance used for newcastle disease hemagglutination inhibition test and preparation method thereof

The invention relates to a positive serum national standard substance used for a newcastle disease hemagglutination inhibition test and a preparation method thereof. In the positive serum national standard substance used for the newcastle disease hemagglutination inhibition test, Newcastle Disease Virus (NDV) La Sota strain virus and inactivated vaccine immune SPF (Specific Pathoge Free) chicken are utilized to prepare hyperimmune serum to be used as a candidate, through the processes of candidate detection, standard substance preparation, detection, split charging, freeze-drying and the like, the positive serum international standard substance used for the newcastle disease hemagglutination inhibition test obtained by NIBSC (National Institute for Biological Standards and Control) is taken as a reference to carry out a red blood cell agglutination inhibition test to determinate a valence of the standard substance, and through a uniformity test, a stability test, cooperation calibration and data statistics, a constant valence value is ensured to be accurate, and the positive serum national standard substance used for the newcastle disease hemagglutination inhibition test is prepared. The method disclosed by the invention makes the standard substance preparation more scientific, rigorous and perfect according to the standard substance preparation process.
Owner:CHINA INST OF VETERINARY DRUG CONTROL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products